Gastrointestinal Bleeding Treatment Market Growth, Share and Forecast 2034
Global Gastrointestinal Bleeding Treatment Market Growth, Size, Trends Analysis- By Product, By GI Tract Division, By Onset, By End Use - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jul-2025 | Report ID: HLCA25218 | Pages: 1 - 255 | Formats*: |
| Category : Healthcare | |||
Global Gastrointestinal Bleeding Treatment Market Introduction and Overview
According to SPER Market Research, the Global Gastrointestinal Bleeding Treatment Market is estimated to reach USD 1.87 billion by 2034 with a CAGR of 8.16%.
The report includes an in-depth analysis of the Global Gastrointestinal Bleeding Treatment Market, including market size and trends, product mix, Applications, and supplier analysis. The growing prevalence of gastrointestinal (GI) disorders such as peptic ulcers, gastritis, GERD, IBD, and colorectal cancer, along with the widespread use of NSAIDs, is driving an increase in GI bleeding cases. The aging population, which is more vulnerable to gastrointestinal bleeding due to physiological changes, further contributes to market growth. Studies show that hospital admissions for upper GI bleeding increase 30-fold between the third and ninth decades of life. Additionally, advancements in endoscopic and diagnostic imaging technologies are improving detection and treatment outcomes. GI bleeding refers to any bleeding within the digestive tract, from the esophagus to the anus.
By Product:
The market is segmented by product into endoscopic hemostatic devices, closure devices, and others, with endoscopic hemostatic devices holding the largest share. This segment includes mechanical and thermal devices, widely used for their high efficacy and minimally invasive nature. These tools offer precise control and easy application, making them ideal for managing both acute and chronic gastrointestinal bleeding. Ongoing advancements in endoscopic technology, such as improved designs and enhanced visualization, continue to boost the effectiveness, safety, and adoption of these devices.
By GI tract division:
The gastrointestinal bleeding treatment market is divided into upper and lower GI tract segments, with the upper GI tract segment leading due to the high occurrence of peptic ulcers. Increased cases of gastritis, esophagitis, Mallory-Weiss tears, and certain cancers also contribute to the dominance of this segment.
By Onset:
The gastrointestinal bleeding treatment market is categorized by onset into acute and chronic types, with the acute segment demonstrating significant growth prospects. Acute GI bleeding, characterized by a sudden onset of bleeding in the digestive tract, typically requires immediate medical attention. Factors such as increased NSAID usage, alcohol consumption, and Helicobacter pylori infection contribute to its rising incidence. Additionally, advancements in hemostatic agents and the growing use of minimally invasive procedures have significantly boosted the demand for effective treatments in managing acute gastrointestinal bleeding cases.
By End User:
The gastrointestinal bleeding treatment market is segmented by end-use into hospitals, ambulatory surgical centers, and others, with hospitals emerging as the dominant segment. This leadership is attributed to their key role in treating both acute and chronic gastrointestinal conditions. Hospitals provide a full spectrum of treatments, including advanced endoscopic and surgical procedures. Equipped with specialized medical professionals, modern infrastructure, and state-of-the-art technologies, they are well-positioned to handle complex cases. Additionally, hospitals often function as referral centers, further reinforcing their importance in gastrointestinal bleeding treatment.
Regional Insights:
North America holds a leading position in the global gastrointestinal bleeding treatment market, driven by a high prevalence of gastrointestinal disorders such as peptic ulcers. The region benefits from a well-established healthcare infrastructure and widespread adoption of advanced treatment options. A strong presence of key industry players, along with robust research and development efforts, further enhances market growth. Additionally, favorable reimbursement policies and rising healthcare spending contribute to North America's continued dominance and expansion in the gastrointestinal bleeding treatment landscape.
Market Competitive Landscape:
The global Gastrointestinal Bleeding Treatment Market is highly consolidated. Some of the market key players are Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc., STERIS PLC, US Medical Innovations.
Recent Developments:
In September 2022, Medtronic plc obtained clearance from the U.S. Food and Drug Administration for its Nexpowder endoscopic hemostasis system, enabling the company to broaden its product portfolio in the U.S. market.
In May 2018, Cook Medical received U.S. FDA clearance to market its Hemospray device for managing certain types of non-variceal gastrointestinal (GI) bleeding. The device is approved for controlling both upper and lower GI bleeding and contributed to an increase in the company’s sales.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Product, By GI Tract Division, By Onset, By End Use |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa |
| Companies Covered | Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc., STERIS PLC, US Medical Innovations. |
Key Topics Covered in the Report
- Global Gastrointestinal Bleeding Treatment Market Size (FY’2021-FY’2034)
- Overview of Global Gastrointestinal Bleeding Treatment Market
- Segmentation of Global Gastrointestinal Bleeding Treatment Market By Product (Endoscopic hemostatic devices, Closure devices, Other products)
- Segmentation of Global Gastrointestinal Bleeding Treatment Market By GI Tract Division (Upper GI tract, Lower GI tract)
- Segmentation of Global Gastrointestinal Bleeding Treatment Market By Onset (Acute, Chronic)
- Segmentation of Global Gastrointestinal Bleeding Treatment Market By End-use (Hospitals, Ambulatory surgical centers (ASCs), Other end-users)
- Statistical Snap of Global Gastrointestinal Bleeding Treatment Market
- Expansion Analysis of Global Gastrointestinal Bleeding Treatment Market
- Problems and Obstacles in Global Gastrointestinal Bleeding Treatment Market
- Competitive Landscape in the Global Gastrointestinal Bleeding Treatment Market
- Details on Current Investment in Global Gastrointestinal Bleeding Treatment Market
- Competitive Analysis of Global Gastrointestinal Bleeding Treatment Market
- Prominent Players in the Global Gastrointestinal Bleeding Treatment Market
- SWOT Analysis of Global Gastrointestinal Bleeding Treatment Market
- Global Gastrointestinal Bleeding Treatment Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces
5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry
5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Global Gastrointestinal Bleeding Treatment Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Gastrointestinal Bleeding Treatment Market
7.Global Gastrointestinal Bleeding Treatment Market, By Product, (USD Million) 2021-2034
7.1.Endoscopic hemostatic devices7.1.1.Endoscopic mechanical devices7.1.2.Endoscopic thermal devices7.2.Closure devices7.3.Other products
8.Global Gastrointestinal Bleeding Treatment Market, By Onset, (USD Million) 2021-2034
8.1.Acute8.2.Chronic
9.Global Gastrointestinal Bleeding Treatment Market, By End-use, (USD Million) 2021-2034
9.1.Hospitals9.2.Ambulatory surgical centers (ASCs)9.3.Other end-users
10.Global Gastrointestinal Bleeding Treatment Market, (USD Million) 2021-2034
10.1.Global Gastrointestinal Bleeding Treatment Market Size and Market Share
11.Global Gastrointestinal Bleeding Treatment Market, By Region, 2021-2034 (USD Million)
11.1.Asia-Pacific
11.1.1.Australia11.1.2.China11.1.3.India11.1.4.Japan11.1.5.South Korea11.1.6.Rest of Asia-Pacific
11.2.Europe
11.2.1.France11.2.2.Germany11.2.3.Italy11.2.4.Spain11.2.5.United Kingdom11.2.6.Rest of Europe
11.3.Middle East and Africa
11.3.1.Kingdom of Saudi Arabia11.3.2.United Arab Emirates11.3.3.Qatar11.3.4.South Africa11.3.5.Egypt11.3.6.Morocco11.3.7.Nigeria11.3.8.Rest of Middle-East and Africa
11.4.North America
11.4.1.Canada11.4.2.Mexico11.4.3.United States
11.5.Latin America
11.5.1.Argentina11.5.2.Brazil11.5.3.Rest of Latin America
12.Company Profile
12.1.Boston Scientific Corporation
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.CONMED Corporation
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.Cook Group
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.ERBE Elektromedizin GmbH
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.Medtronic PLC
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.Olympus Corporation
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.Ovesco Endoscopy AG
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.Pfizer Inc.
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.STERIS PLC
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.US Medical Innovations
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Gastrointestinal Bleeding Treatment Market is projected to reach USD 1.87 billion by 2034, growing at a CAGR of of 8.16% during the forecast period.
Gastrointestinal Bleeding Treatment Market grew in Market size from 2025. The Market is expected to reach USD 1.87 billion by 2034, at a CAGR of 8.16% during the forecast period.
Gastrointestinal Bleeding Treatment Market CAGR of 8.16% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Gastrointestinal Bleeding Treatment Market size is USD 1.87 billion from 2025 to 2034.
Gastrointestinal Bleeding Treatment Market is covered By Product, By GI Tract Division, By Onset, By End Use
The North America is anticipated to have the highest Market share in the Gastrointestinal Bleeding Treatment Market.
Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Medtronic PLC, Olympus Corporation, Ovesco Endoscopy AG, Pfizer Inc., STERIS PLC, US Medical Innovations.
The report includes an in-depth analysis of the Global Gastrointestinal Bleeding Treatment Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
